Year: 2004
Type: dissertation
Abstract: It has long been known that N-containing bisphosphonates (BPs) can reduce osteoclast number by inducing apoptotic cell death in osteoclasts.As potent inhibitors of bone resorption, they are widely used for the treatment of bone disorders that are due to increased osteoclast activity i.e. postmenopausal osteoporosis, Paget's disease, tumoral bone disease, and particle induced osteolysis around metal implant.BPs also decrease breakdown of type II collagen
Author: 김형규
Language: English
Topic: Bone health and treatments
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2938781882